Barely Significant
← all excerpts

Radiomic assessment as a method for predicting tumor mutation burden (TMB) of bladder cancer patients: a feasibility study.

BMC Cancer · 2021 · PMC8285848 · PMID 34271855

Europe PMCDOI
1
hedged sentence
0.1930
closest p · 3.9× alpha
0.1930
boldest claim

The sentences

showed a trendp = 0.193not close (p > 0.1)
Log-rank test showed a trend of shorter median OS (35.0 months vs. 56.4 months, p = 0.193) in the low TMB group, although the p -value were not significant (Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.